martes, 5 de noviembre de 2013

National Guideline Clearinghouse | Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition).

full-text ►
National Guideline Clearinghouse | Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition).

British Committee for Standards in Haematology
National Guideline Clearinghouse (NGC)

November 4, 2013


Guideline Title
Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition).
 
Bibliographic Source(s)
Collins PW, Chalmers E, Hart DP, Liesner R, Rangarajan S, Talks K, Williams M, Hay CR, UK Haemophilia Centre Doctors. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization. Br J Haematol. 2013 Jan;160(2):153-70. PubMed External Web Site Policy
 
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: Hay CR, Brown S, Collins PW, Keeling DM, Liesner R. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors Organisation (UKHCDO). Br J Haematol 2006;133:591–605.


2013 Jan;160(2):153-70. doi: 10.1111/bjh.12091. Epub 2012 Nov 15.

Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.

Source

School of Medicine, Cardiff University, University Hospital of Wales, Wales, UK.


 

No hay comentarios:

Publicar un comentario